Nymox Pharmaceutical Corporation filed its 20-F on May 02, 2023 for the period ending Dec 31, 2022. In this report its auditor, TPS Thayer, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2505 USD | 0.00% | -7.22% | -57.54% |
1st Jan change | Capi. | |
---|---|---|
-57.54% | 23.39M | |
+20.41% | 47.02B | |
+49.22% | 41.86B | |
+0.12% | 41.76B | |
-4.27% | 28.8B | |
+11.75% | 26.05B | |
-21.81% | 19.15B | |
+4.45% | 12.55B | |
+28.84% | 12.34B | |
-4.99% | 11.82B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Auditor Raises 'Going Concern' Doubt